SB

Shreekant Bagaria

Active Director Additional Director DIN 02770335
DIN 02770335 First appointment Nov 2009 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Nov 2009
Shareholding value •••• Premium profile

About Shreekant Bagaria

Data last updated:

Shreekant Bagaria is an Additional Director at Ganpati Agrovet Private Limited (since 2025), Director at Bagaria Chemicals Private Limited (since 2022) and Director at Biosmith Pharmachem Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Agriculture, Chemicals and Materials and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹32.45 Cr; the largest is Ganpati Agrovet Private Limited at ₹15.61 Cr (FY 2025). Earlier, Shreekant Bagaria was a Director at Ganpati Derivative Services Private Limited (2009–2022) and Partner at Pyramid Tradelinks Llp (2016–2022).

DIN 02770335
Primary Designation Additional Director
Industry Agriculture
First Appointment 10 Nov 2009
Oldest Company Age 8 yrs
Largest company Ganpati Agrovet Private Limited · ₹15.61 Cr (FY 2025)
Combined revenue ₹32.45 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ganpati Agrovet Private Limited U01100DL2018PTC340149
Additional Director27 Feb 20252018₹15.61 Cr (FY 2025)Active
Bagaria Chemicals Private Limited U24110DL2022PTC402782
Director03 Aug 20222022₹15.22 Cr (FY 2025)Active
Biosmith Pharmachem Private Limited U24230DL2021PTC382752
Director25 Jun 20212021₹1.63 Cr (FY 2023)Under Process Of Striking Off
Partner06 Jun 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Nov 20092009₹49.4 Lakh (FY 2017)Converted To Llp
Partner23 Mar 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bagaria Chemicals Private Limited
Biosmith Pharmachem Private Limited
Ganpati Agrovet Private Limited
Ganpati Derivative Services Llp
Premium access

Shareholding and investment profile for Shreekant Bagaria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreekant Bagaria

Shreekant Bagaria currently holds 4 directorships: Ganpati Agrovet Private Limited (Additional Director, since 27 Feb 2025, revenue ₹15.61 Cr (FY 2025)); Bagaria Chemicals Private Limited (Director, since 03 Aug 2022, revenue ₹15.22 Cr (FY 2025)); Biosmith Pharmachem Private Limited (Director, since 25 Jun 2021, revenue ₹1.63 Cr (FY 2023)); Ganpati Derivative Services Llp (Partner, since 06 Jun 2024).

Shreekant Bagaria was first appointed on 10 Nov 2009 as Director at Ganpati Derivative Services Private Limited. The most recent appointment on record is 27 Feb 2025 at Ganpati Agrovet Private Limited.

The 3 current companies of Shreekant Bagaria that report revenue have a combined latest revenue of ₹32.45 Cr: Ganpati Agrovet Private Limited ₹15.61 Cr (FY 2025); Bagaria Chemicals Private Limited ₹15.22 Cr (FY 2025); Biosmith Pharmachem Private Limited ₹1.63 Cr (FY 2023).

Shreekant Bagaria held 2 earlier board appointments: Ganpati Derivative Services Private Limited (Director, 10 Nov 2009 to 15 Dec 2022); Pyramid Tradelinks Llp (Partner, 23 Mar 2016 to 22 Feb 2022).

The current boards of Shreekant Bagaria's companies include Neha Goyal (Ganpati Agrovet Private Limited), Pawan Bagaria Kumar (Ganpati Agrovet Private Limited), Divyang Lohariwala (Biosmith Pharmachem Private Limited), Amit Bagaria (Ganpati Derivative Services Llp), Govind Ram Bagaria (Ganpati Derivative Services Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available